SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverRVTY
HealthcareNYSEUSD

Revvity

$001234567890012345678900123456789.0012345678900123456789+10.3%
52w low (est.) $87.73$142.37 52w high (est.)
Peers
Market data
Market cap
$12.53B
52-week range
$81.22 – $118.30
Beta (vs market)
1.09
Sector
Healthcare
Valuation
P/E ratio
54.0x
DCF fair value
$64.34
Margin of safety
-42.4%
Forward P/E
19.3x
PEG ratio
0.69
Dividend yield
0.25%
Quality & efficiency
Moat score
52/100
Return on equity
3.2%
Profit margin
8.3%
Debt / equity
0.47
Growth & analysts
Revenue growth (YoY)
+7.0%
Analyst target
$114.73
Target upside
+2.7%
Analysts covering
15

About Revvity

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Valuation

ValueGrowthProfitHealthIncome29QUALITY
Overall Rating
31
Reduce
Reduce
Moat Score52
DCF Intrinsic Value
$64.34-42.4% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$12.53B
P/E Ratio
54.0
Dividend Yield
0.25%
Revenue Growth
+7.0%
Profit Margin
8.3%
ROE
3.2%
Debt / Equity
0.47
Beta
1.09
vs Healthcare sector:P/E 54 vs 28 Moat 52 vs 7Yield 0.25% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · RVTY